Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

HIK

Ранг среди акций #25480
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Цена акции
$22.38
Рыночная капитализация
$46.33M
Изменение (1 день)
0.48%
Изменение (1 год)
-53.93%
Страна
GB
Торговля Hikma Pharmaceuticals PLC (HIK)

Категория

Healthcare
Выручка компании Hikma Pharmaceuticals PLC (HIK)
Выручка на Oct 2026 TTM: 0
Согласно последним финансовым отчетам Hikma Pharmaceuticals PLC, текущая выручка компании (TTM) составляет 0. В 2026 году компания получила выручку 0 равна выручке в 2026 году, которая составила 0. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Hikma Pharmaceuticals PLC с 2026 по 2026
Выручка на конец каждого года
Год Выручка Изменить
Недостаточно данных для указанных дат.
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
- -
DE
- -
DE
- -
JP
- -
CH
$6.61B -
IN